Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: The gut microbiome enhances breast cancer immunotherapy following bariatric surgery

PROVIDER: PRJNA1233226 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR32609900_1.fastq.gz	Fastqsanger.gz
	SRR32609900_2.fastq.gz	Fastqsanger.gz
	SRR32609901_1.fastq.gz	Fastqsanger.gz
	SRR32609901_2.fastq.gz	Fastqsanger.gz
	SRR32609902_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 256

Similar Datasets

The gut microbiome enhances breast cancer immunotherapy following bariatric surgery

Project description:The gut microbiome enhances breast cancer immunotherapy following bariatric surgery

| PRJNA1231419 | ENA

The gut microbiome enhances breast cancer immunotherapy following bariatric surgery

Project description:Bariatric surgery is associated with improved breast cancer (BC) outcomes, including greater immunotherapy effectiveness in a pre-clinical BC model. A potential mechanism of bariatric surgery-associated protection is through the gut microbiota. Here, we demonstrate the dependency of improved immunotherapy response on the post-bariatric surgery gut microbiome via fecal microbial transplant. Cecal contents were isolated from either obese controls that received sham surgery or formerly obese mice following bariatric surgery-induced weight loss and transferred by FMT to lean recipients. Response to αPD-1 immunotherapy was significantly improved following FMT from formerly obese bariatric-surgery treated mice. Microbes can impact tumor burden through microbially derived metabolites produced or modified by gut microbiota including branched chain amino acids (BCAA). Circulating BCAA correlated significantly with NK T cell content in the tumor microenvironment in both donor mice after bariatric surgery and in FMT recipients of donor cecal content after bariatric surgery compared to obese sham controls. Findings implicate a role of microbially-derived BCAA in activating anti-tumor immunity that is dependent upon bariatric surgery. Importantly, when stool from a patient who exhibited 25% weight loss post-bariatric surgery was transplanted into recipient mice and compared to the patient’s pre-bariatric surgery stool transplant. Patient samples post bariatric surgery significantly reduced tumor burden by 2.4-fold and immunotherapy effectiveness was doubled. Taken together, findings suggest that reinvigorating anti-tumor immunity may be dependent upon microbially derived metabolites such as BCAA.

2025-04-14 | GSE291031 | GEO

Bariatric surgery reduces obesity associated breast cancer and enhances response to immunotherapy

Project description:Bariatric surgery reduces obesity associated breast cancer and enhances response to immunotherapy

| PRJNA731481 | ENA

Bariatric surgery reduces obesity associated breast cancer and enhances response to immunotherapy [Tumor - breast cancer RNA-seq]

Project description:Bariatric surgery reduces obesity associated breast cancer and enhances response to immunotherapy [Tumor - breast cancer RNA-seq]

| PRJNA731483 | ENA

Project description:Bariatric Surgery Gut Microbiome

| PRJNA1216567 | ENA

Project description:The Gut Microbiota following Bariatric Surgery

| PRJNA668472 | ENA

Oral microbiome changes in subjects with obesity following bariatric surgery compared to lean counterparts

Project description:oral microbiome in obese following bariatric surgery

| PRJEB75645 | ENA

Bariatric surgery reduces obesity associated breast cancer and enhances response to immunotherapy [Mammary Fat Pad RNA-seq]

Project description:Bariatric surgery reduces obesity associated breast cancer and enhances response to immunotherapy [Mammary Fat Pad RNA-seq]

| PRJNA731484 | ENA

Project description:Gut microbiome changes after bariatric surgery